...
首页> 外文期刊>Journal of clinical psychopharmacology >Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence.
【24h】

Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence.

机译:选择性5-羟色胺再摄取抑制剂的停用:副作用和其他影响药物依从性的因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Patients with major depression discontinue taking their antidepressants for many reasons. Although side effects are often cited as the reason for discontinuation, few prospective studies have addressed this question, and none has specifically examined discontinuation in patients with severe depression. METHOD: Inpatients and outpatients treated with a selective serotonin reuptake inhibitor for major depressive disorder were identified after admission. Three months later, patients were contacted and interviewed to determine antidepressant usage and the side effects experienced, including when these were experienced and their severity. RESULTS: Between October 2001 and April 2003, 406 English- or Spanish-speaking patients aged 18 to 75 years were followed up. One in 4 patients discontinued the index antidepressant. Among specific side effects noted, only "change in weight" and "anxiety" were significant predictors of discontinuation after controlling for confounders. Experiencing 1 or more "extremely" bothersome side effects was associated with more than a doubling of the risk of discontinuation, but the presence of side effects and side effects less severe than "extremely" bothersome were not significant predictors. There were no differences among selective serotonin reuptake inhibitor antidepressants in either the presence/absence of side effects or in the discontinuation rates. CONCLUSION: The results suggest that the contribution of side effects to antidepressant discontinuation is more complex than previously suggested. Disparate findings from earlier studies may reflect aspects of study design, such as examining populations whose severity of depression varied widely or not controlling for important confounding factors. Future research should separately examine high-risk groups (or control for severity of depression) and carefully rule out other potential contributors to discontinuation.
机译:目的:重度抑郁症患者出于多种原因而停止服用抗抑郁药。尽管副作用经常被认为是停药的原因,但很少有前瞻性研究解决该问题,并且还没有专门检查重度抑郁症患者的停药。方法:入院后确定接受选择性5-羟色胺再摄取抑制剂治疗的重度抑郁症的住院和门诊患者。三个月后,与患者接触并进行了访谈,以确定抗抑郁药的使用情况以及所经历的副作用,包括何时经历抗抑郁药及其严重程度。结果:2001年10月至2003年4月,对406名18至75岁的英语或西班牙语患者进行了随访。四分之一的患者停用了抗抑郁指数药物。在指出的特定副作用中,只有“体重变化”和“焦虑”是控制混杂因素后停药的重要预测指标。经历1种或多种“极端”麻烦的副作用与停药风险增加一倍以上有关,但副作用的存在和严重程度低于“极端”麻烦的副作用并不是重要的预测指标。选择性5-羟色胺再摄取抑制剂抗抑郁药在有无副作用或停药率方面无差异。结论:结果表明,副作用对抗抑郁药的终止作用比以前建议的更为复杂。较早研究的不同发现可能反映了研究设计的各个方面,例如检查抑郁症严重程度差异很大或无法控制重要混杂因素的人群。未来的研究应单独检查高风险组(或控制抑郁症的严重程度),并仔细排除其他可能导致停药的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号